Mirna Therapeutics, Inc.

skip to the main content area of this page

About Mirna Therapeutics

Mirna Therapeutics, Inc. (Mirna) is a discovery-stage biopharmaceutical research and development company focused on miRNA-directed human oncology therapies. Featuring world-class research capabilities, a strong understanding of miRNA and cancer biology, and an expansive IP portfolio, Mirna Therapeutics is well-positioned to capitalize on the emerging field of miRNA-based therapeutics.

About miRNA Replacement Therapy

miRNA Replacement Therapy is a new approach to treat human disease. It involves the re-introduction of a synthetic version of a miRNA that is depleted in the diseased tissue. Since the synthetic and the natural miRNA are virtually indistinguishable, miRNA-based therapeutics have the potential of not exhibiting non-specific side effects. The synthetic miRNA counteracts disease-dependent processes and induces a therapeutic response.

About microRNA

microRNAs (miRNAs) are small, non-coding RNA molecules that occur naturally in human cells. Misregulation of these critical cellular components is a frequent event in the development of genetically manifested human disease. Mirna Therapeutics is developing treatments that have the promise of being effective in humans by restoring normal miRNA function.